This webinar will provide participants a good understanding of FDA requirements for training and provide recommendations for implementation.
Why Should You Attend:
No or inadequate training of employees is one of most frequently cited deviations in FDA inspectional observations and warning letters. Trainings are either not planned, not conducted, not evaluated or not documented as expected by inspectors. On the other hand it has been is estimated that about 5% of employee's time is spent for training. So there seems to be lack of understanding on what the regulations are, their interpretations and expectations of inspectors.
Learning Objectives:
Who Will Benefit:
Pharmaceutical development and quality control, API manufacturers, medical device development and manufacturers, contract laboratories and CROs will benefit from this training